|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.54 USD | +0.55% |
|
+1.78% | +1.02% |
| Capitalization | 846.99Cr 725.28Cr 674.49Cr 628.83Cr 1.17TCr 76TCr 1.26TCr 7.77TCr 3.05TCr 37TCr 3.18TCr 3.11TCr 1,33900Cr | P/E ratio 2025 * |
93.7x | P/E ratio 2026 * | 63.6x |
|---|---|---|---|---|---|
| Enterprise value | 847.14Cr 725.41Cr 674.61Cr 628.94Cr 1.18TCr 76TCr 1.26TCr 7.77TCr 3.05TCr 37TCr 3.18TCr 3.11TCr 1,33900Cr | EV / Sales 2025 * |
3.73x | EV / Sales 2026 * | 3.35x |
| Free-Float |
98.99% | Yield 2025 * |
2.11% | Yield 2026 * | 2.27% |
Last Transcript: American Healthcare REIT, Inc.
| 1 day | +0.55% | ||
| 1 week | +1.78% | ||
| Current month | +1.02% | ||
| 1 month | +0.61% | ||
| 3 months | +17.21% | ||
| 6 months | +29.71% | ||
| Current year | +1.02% |
| 1 week | 46.56 |  | 48.6 |
| 1 month | 45.03 | | 48.76 |
| Current year | 45.03 | | 48.6 |
| 1 year | 26.48 | | 51.02 |
| 3 years | 12.63 | | 51.02 |
| 5 years | 12.63 | | 51.02 |
| 10 years | 12.63 | | 51.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Danny Prosky
CEO | Chief Executive Officer | 61 | 01/10/2021 |
Brian Peay
DFI | Director of Finance/CFO | 60 | 13/06/2016 |
Gabriel Willhite
COO | Chief Operating Officer | 45 | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Hanson
CHM | Chairman | 55 | 01/01/2015 |
Mathieu Streiff
BRD | Director/Board Member | 51 | 01/10/2021 |
Brian Flornes
BRD | Director/Board Member | 62 | 01/02/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +1.78% | +74.65% | - | 846.99Cr | |
| +0.32% | +1.06% | +49.61% | +158.92% | 13TCr | |
| +1.04% | -0.99% | +31.87% | +52.09% | 3.55TCr | |
| +0.38% | +1.60% | +20.66% | +58.60% | 1.31TCr | |
| +0.60% | +2.56% | -14.50% | -38.47% | 1.17TCr | |
| +0.21% | +3.71% | +43.44% | +92.64% | 835.37Cr | |
| +0.88% | +1.95% | +8.13% | -17.98% | 607.97Cr | |
| +0.78% | +1.83% | +17.12% | +46.42% | 484.49Cr | |
| +1.14% | +0.84% | +37.13% | +123.61% | 457.93Cr | |
| -0.81% | +7.65% | +33.21% | -11.70% | 409.8Cr | |
| Average | +0.47% | +2.16% | +30.13% | +51.57% | 2.25TCr | |
| Weighted average by Cap. | +0.45% | +1.11% | +40.12% | +110.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 227.13Cr 194.49Cr 180.87Cr 168.63Cr 315.08Cr 20TCr 337.95Cr 2.08TCr 819.02Cr 9.79TCr 851.79Cr 834.32Cr 36TCr | 253.16Cr 216.78Cr 201.6Cr 187.95Cr 351.19Cr 23TCr 376.67Cr 2.32TCr 912.86Cr 11TCr 949.4Cr 929.93Cr 40TCr |
| Net income | 8.45Cr 7.23Cr 6.73Cr 6.27Cr 12Cr 761.36Cr 13Cr 77Cr 30Cr 364.24Cr 32Cr 31Cr 1.34TCr | 14Cr 12Cr 11Cr 10Cr 19Cr 1.22TCr 20Cr 124.13Cr 49Cr 583.47Cr 51Cr 50Cr 2.14TCr |
| Net Debt | 14.85L 12.72L 11.83L 11.03L 20.6L 13Cr 22.1L 1.36Cr 53.55L 6.4Cr 55.69L 54.55L 23Cr | 16.54L 14.16L 13.17L 12.28L 22.94L 15Cr 24.61L 1.52Cr 59.63L 7.13Cr 62.02L 60.75L 26Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 47.54 $ | +0.55% | 11,19,529 |
| 09/26/09 | 47.28 $ | -0.13% | 12,64,181 |
| 08/26/08 | 47.34 $ | -0.02% | 18,76,168 |
| 07/26/07 | 47.35 $ | +0.47% | 14,45,818 |
| 06/26/06 | 47.13 $ | +0.90% | 26,69,378 |
Delayed Quote Nyse, January 13, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AHR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition